Press Releases

Washington, D.C. (March 17, 2016) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the introduction today by Senators Alexander and Murray of the FDA and NIH Workforce Authorities Modernization Act:

The U.S. Senate was unable to advance a national solution to GMO food labeling.  It is essential for Senate leaders to continue working to reach a much-needed compromise over the coming days, as failure to move forward allows costly and confusing state-based measures such as Vermont’s GMO food labeling law to take effect in July.   

BIO Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s proposed Part B Drug Payment Model and ASPE Issue Briefs...

The Biotechnology Innovation Organization (BIO) is pleased to announce that the Honorable Dennis McGinn, Assistant Secretary of the Navy, Energy, Installations & Environment, will address biofuel and biorefining technology developers. McGinn will provide remarks during the “Overcoming Challenges to Biorefinery Scale Up” plenary scheduled for 4:30pm on Monday, April 18th.

Washington, D.C. (March 2, 2016) – The Biotechnology Innovation Organization (BIO) has announced a new partnership with UniFirst Corporation (NYSE: UNF), an industry leader in the supply and servicing of uniforms, workwear, and facility products, to add managed uniform, protective clothing, and custom corporate image apparel programs to the BIO Business Solutions® offerings. As a supplier partner, UniFirst is now part of BIO’s exclusive Business Solutions ® program which is helping thousands of companies save on items they need to run a successful biotechnology enterprise.

Legislation enhances transparency, protects farmers

Washington, D.C. (March 1, 2016) – The Biotechnology Innovation Organization (BIO) applauds bipartisan action today by the Senate Agriculture Committee to advance a biotech food labeling solution as an alternative to a costly and confusing patchwork of state laws.

Washington, D.C. (February 26, 2016) – The Biotechnology Innovation Organization (BIO) Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s White House announcement of actions to accelerate the Precision Medicine Initiative:

“BIO extends our congratulations to Dr. Califf on his confirmation as Commissioner of the FDA, a job that carries tremendous responsibility in protecting public health and advancing biotechnology innovation. 

The Biotechnology Innovation Organization (BIO) today announces the “must attend” Breakout Sessions for BIO’s 2016 World Congress on Industrial Biotechnology. The 2016 World Congress on Industrial Biotechnology program will feature 70 sessions in eight 8 tracks over three days. This year’s conference will be held April 17-20 in San Diego, CA at the San Diego Convention Center. 

Legislation eliminates confusion, enhances transparency

Biofuels Digest, a top trade publication for the industrial biotech industry, recently published its list of the “Top 100 People in the Advanced Bioeconomy” for 2016. Brent Erickson, Executive Vice President of the Biotechnology Innovation Organization (BIO)’s Industrial and Environmental Section, was number ten.

The Rosalind Franklin Award is given annually to an outstanding woman in the industrial biotechnology sector who has made significant contributions to the advancement of the biobased economy and biotech innovation. The Biotechnology Innovation Organization (BIO) will begin accepting nominations for the Award today. The award will be presented and the winner will deliver remarks at the 2016 World Congress on Industrial Biotechnology in San Diego, California, which will be held April 17-20, 2016 at the San Diego Convention Center.

 

The Biotechnology Innovation Organization (BIO) applauds the passage yesterday by the Senate Health Committee of legislative components of the bipartisan Innovation Initiative to accelerate the pace of medical advancement.

 

Elements of the President’s budget proposal for 2017 directly threaten his Administration’s goal of curing cancer through advances in precision medicine

Ad Launches Campaign Spotlighting Benefits and Value of Medical Breakthroughs

Innovative biopharmaceutical industry focused on value, advocating for needed reforms

BIO applauds the House of Representatives for approving the SEC Small Business Advocate Act (H.R. 3784) and the Small Business Capital Formation Enhancement Act (H.R. 4168). These bills would enhance the role that small businesses play in the decision-making process at the Securities and Exchange Commission, ensuring that SEC policies support the growth of emerging biotech innovators.

 The ninth annual George Washington Carver Award will recognize an individual who has made a significant contribution to building the biobased economy by applying industrial biotechnology to create sustainable and environmentally friendlier products. The Biotechnology Innovation Organization (BIO) will begin accepting nominations for the Award today, February 01, 2016. The deadline for nominations is February 20, 2016. The award will be presented at the 2016 World Congress on Industrial Biotechnology in San Diego, California, which will be held April 17-20, 2016 at the San Diego Convention.

The Biotechnology Innovation Organization (BIO) opened registration today for the 2016 World Congress on Industrial Biotechnology. The conference will be held April 17-20, 2016 in San Diego, California.

Washington, D.C. (January 21, 2016) – The Biotechnology Innovation Organization (BIO) applauds the Industry Declaration on Combating Antimicrobial Resistance, signed by 85 biopharmaceutical and diagnostic companies and released today at the World Economic Forum in Davos, Switzerland.

BVGH engages leading biopharmaceutical companies in partnerships and programs to address challenging global health issues